Lipid rafts, KCa/ClCa/Ca2 + channel complexes and EGFR signaling: Novel targets to reduce tumor development by lipids?

• This review describes lipid raft ion channel complexes and EGFR in cancer cells.
• Complexes are composed of Ca2 +-activated K+ (KCa), Cl− (ClCa) and Ca2 + channels.
• The modification of these lipid raft complexes by lipids is presented.
• This could lead to a novel therapeutic approach in tumor development.

Membrane lipid rafts are distinct plasma membrane nanodomains that are enriched with cholesterol, sphingolipids and gangliosides, with occasional presence of saturated fatty acids and phospholipids containing saturated acyl chains. It is well known that they organize receptors (such as Epithelial Growth Factor Receptor), ion channels and their downstream acting molecules to regulate intracellular signaling pathways. Among them are Ca2 + signaling pathways, which are modified in tumor cells and inhibited upon membrane raft disruption. In addition to protein components, lipids from rafts also contribute to the organization and function of Ca2 + signaling microdomains. This article aims to focus on the lipid raft KCa/ClCa/Ca2 + channel complexes that regulate Ca2 + and EGFR signaling in cancer cells, and discusses the potential modification of these complexes by lipids as a novel therapeutic approach in tumor development. This article is part of a Special Issue entitled: Membrane channels and transporters in cancers.

Figure optionsDownload high-quality image (159 K)Download as PowerPoint slide